Perciclib
Antineoplastic cyclin-dependent kinase (CDK) inhibitor indicated for the treatment of patients with hormone receptor positive advanced breast cancer (HR+HER2-).
Therapeutic Area
Oncology
Active Ingredient
Palbociclib
Line
Oncology
Presentaciones
125 mg capsules x 21
100 mg capsules x 21
75 mg capsules x 21
